MedPath

Emesis and Nasal therapy in chronic plaque psoriasis

Phase 2/3
Not yet recruiting
Conditions
Other psoriasis. Ayurveda Condition: MANDALAKUSHTHAH/KAPAJAKUSHTHAH,
Registration Number
CTRI/2025/03/083338
Lead Sponsor
National Institute of Ayurveda
Brief Summary

To study the comparative efficacy of Vamana and Nasya karma in the management of Mandal Kustha (Psoriasis), the study will include two groups: a comparator group and an intervention group. in the comparator group, the Vamana procedure with Madanphala Pippali( approximately 10 grams) in Kasaya form will be administered to patients. In the intervention group, Nasya procedure will be performed using Twagadi Taila (0.3 ml in each nostril) for seven consecutive days, with a gap of one day between sessions, repeated three times over a period of 23 days. Changes in PASI Score (psoriasis arear and severity index) and changes in DLQI ( The Dermatology Life Quality Index) along with Compliance of both the procedure Vamana and Nasya in patient will be assessed.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

(a) Patient with the classical feature of Mandal kustha (plaque psoriasis) (b) Patient not taking any other medication for Mandal kustha (plaque psoriasis) (c) Patient fit for Vaman and Nasya Karma (d) Patient willing to sign consent form for trial (e) The participant with combined PASI score more than 5 to less than 72 will be included (moderate to severe form).

Exclusion Criteria
  • (a) Age below the age 18 years & above the age 60 years (b) Patients suffering from systemic disorders as cardiac problem, uncontrolled Diabetes mellitus, uncontrolled Hypertension, paralysis, malignancy, HIV, HBsAg, Leprosy (c) Patient suffering from Psoriatic Arthritis (d) pregnant and lactating mothers.
  • (e) patient unfit for Vamana and Nasya Karma.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
changes in PASI Score (psoriasis area and severity index)Baseline, 14th day, and 28th day
Secondary Outcome Measures
NameTimeMethod
(a) changes in DLOI (The Dermatology Life Quality Index)(b) compliance of both the procedure Vamana & Nasya

Trial Locations

Locations (1)

National Institute of Ayurveda

🇮🇳

Jaipur, RAJASTHAN, India

National Institute of Ayurveda
🇮🇳Jaipur, RAJASTHAN, India
Dr Sarvesh Kumar Singh
Principal investigator
8739860237
sarveshksingh21@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.